Marseille Elliot, Larson Bruce, Kazi Dhruv S, Kahn James G, Rosen Sydney
Health Strategies International, 555 Fifty-ninth Street, Oakland, California, 94609, United States of America (USA).
Center for Global Health and Development, Boston University, Boston, USA .
Bull World Health Organ. 2015 Feb 1;93(2):118-24. doi: 10.2471/BLT.14.138206. Epub 2014 Dec 15.
Many countries use the cost-effectiveness thresholds recommended by the World Health Organization's Choosing Interventions that are Cost-Effective project (WHO-CHOICE) when evaluating health interventions. This project sets the threshold for cost-effectiveness as the cost of the intervention per disability-adjusted life-year (DALY) averted less than three times the country's annual gross domestic product (GDP) per capita. Highly cost-effective interventions are defined as meeting a threshold per DALY averted of once the annual GDP per capita. We argue that reliance on these thresholds reduces the value of cost-effectiveness analyses and makes such analyses too blunt to be useful for most decision-making in the field of public health. Use of these thresholds has little theoretical justification, skirts the difficult but necessary ranking of the relative values of locally-applicable interventions and omits any consideration of what is truly affordable. The WHO-CHOICE thresholds set such a low bar for cost-effectiveness that very few interventions with evidence of efficacy can be ruled out. The thresholds have little value in assessing the trade-offs that decision-makers must confront. We present alternative approaches for applying cost-effectiveness criteria to choices in the allocation of health-care resources.
许多国家在评估卫生干预措施时,采用世界卫生组织“选择具有成本效益的干预措施”项目(WHO - CHOICE)推荐的成本效益阈值。该项目将成本效益阈值设定为:每避免一个伤残调整生命年(DALY)的干预成本低于该国人均国内生产总值(GDP)年值的三倍。高度具有成本效益的干预措施定义为每避免一个DALY达到人均年GDP的阈值。我们认为,依赖这些阈值会降低成本效益分析的价值,使此类分析过于粗略,无法用于公共卫生领域的大多数决策。使用这些阈值几乎没有理论依据,回避了对适用于当地的干预措施相对价值进行艰难但必要的排序,并且没有考虑真正可承受的情况。WHO - CHOICE阈值为成本效益设定的标准很低,以至于几乎没有有疗效证据的干预措施会被排除。这些阈值在评估决策者必须面对的权衡取舍方面几乎没有价值。我们提出了在卫生保健资源分配选择中应用成本效益标准的替代方法。